U.S. Biotech Stock News

Hamilton Lane (HLNE) is back on investors’ radar after emerging as a balance sheet partner in Pluto Financial Technologies’ new AI-powered lending platform for private markets. This move directly connects the firm to private-asset credit growth. See our latest analysis for Hamilton Lane. The Pluto partnership lands at a time when momentum in Hamilton Lane's shares has been picking up. The 7 day share price return is 9.22% and the 90 day share price return is 24.05% from a latest share price...

Construction milestone and geopolitical interest put Critical Metals in focus Critical Metals (CRML) has formally approved and begun construction of an Arctic-grade, multi-use storage and pilot-plant facility in Qaqortoq, Greenland, a key step for advancing its Tanbreez rare earths project. The company is also setting up a permanent local office in Qaqortoq. Its shares have recently moved sharply, helped by investor attention on Western access to rare earth supply chains and Greenland’s...

Why Buckle stock is back in focus Buckle (BKE) is on investors’ radar after reporting a 5.5% rise in comparable store net sales and 6.5% growth in total net sales for the 5 week period ending January 3, 2026. See our latest analysis for Buckle. The latest sales update comes as Buckle’s share price sits at US$55.61, with a 1 day share price return of 3.19% and a 90 day share price return of 5.46%, while the 1 year total shareholder return of 19.90% and 5 year total shareholder return of...

What recent returns say about Luckin Coffee Luckin Coffee (OTCPK:LKNC.Y) has drawn attention after a mixed stretch for shareholders, with the stock showing a 0.6% gain over the past day and 1.2% over the past week, but negative returns over the past month and past 3 months. See our latest analysis for Luckin Coffee. That recent 1-day and 7-day share price strength comes after a weaker stretch, with a 30-day share price return of 10.1% and a 90-day share price return of 14.2%. The 1-year total...

Serve Robotics (SERV) is back in focus after passing its 2025 goal early by deploying more than 2,000 autonomous delivery robots across U.S. cities and expanding into Fort Lauderdale, alongside fresh analyst coverage and easing short interest. See our latest analysis for Serve Robotics. The recent deployment milestone and fresh analyst coverage have come alongside strong near term momentum, with a 1 day share price return of 14.40% and a 7 day share price return of 48.46% at a latest share...

Silicon Motion Technology (SIMO) is back in focus after iKKO, MediaTek, and SIMO jointly unveiled MindOne, a card sized AI smartphone built around always on AI connectivity, along with fresh visibility from recent investor conferences. See our latest analysis for Silicon Motion Technology. Those AI connectivity headlines and a busy investor conference schedule have arrived alongside a strong run in the shares, with a 7 day share price return of 19.77% and a 1 year total shareholder return of...

In the past quarter, Origin Bancorp (NYSE: OBK) reported third-quarter results with revenue rising 11.5% year on year and earnings per share coming in above analyst forecasts. This outperformance relative to expectations, alongside generally satisfactory results across regional banks, points to resilient operations and sector-wide support for Origin’s performance. With Origin’s third-quarter revenue and earnings surpassing expectations, we’ll now examine how this performance may influence...

If you are wondering whether Mirum Pharmaceuticals' share price still offers value at around US$81.98, it helps to step back and look at what the current market price is really implying. The stock has delivered returns of 3.8% over the last 7 days, 20.7% over the last 30 days, 5.0% year to date and 95.2% over the last year, with a multi year return of 293.6% across three years and 320.8% across five years. These figures may catch the eye of growth focused investors. Recent share price moves...

Recent commentary around StepStone Group (STEP) focuses on its strong compound growth in revenue and earnings, along with gains in assets under management. This has renewed investor interest and raised fresh questions about how to view the stock now. See our latest analysis for StepStone Group. StepStone Group's recent commentary on revenue and earnings growth has been backed by strong price momentum, with a 10.74% 7 day share price return and a 12.96% 90 day share price return, while the 3...

In recent days, BD (Becton, Dickinson and Company) reported the first European prophylactic laparotomy reinforcement case in Greece using its Phasix™ Mesh, following expanded CE-marked approval, new product sizes, and broader availability across Europe and the U.K. for hernia prophylaxis indications. This broader European indication, supported by ongoing PREVENT trial enrollment, points to a potentially wider clinical role for bioabsorbable mesh in high‑risk abdominal surgeries and...

Disc Medicine (IRON) has attracted investors’ attention after submitting a New Drug Application for bitopertin aimed at accelerated FDA review, alongside Phase 2 results for DISC-0974 that suggest broader use with existing JAK inhibitor therapies. See our latest analysis for Disc Medicine. The share price has moved to $80.94 after a 4.63% 1 day share price return. However, the 30 day share price return of a 12.25% decline contrasts with a 14.40% 90 day share price return and a very large 3...

If you are wondering whether First Solar's recent share price justifies the current valuation, you are not alone. This article is built to help you frame that question clearly. The stock last closed at US$246.26, with returns of 28.8% over 1 year, 37.7% over 3 years and 132.2% over 5 years. The year-to-date return of a 10.2% decline and recent 7-day and 30-day returns of 5.7% and 2.8% declines hint at shifting expectations. Recent news coverage of First Solar has focused on its position as a...

Recently, Bank of New York Mellon Corporation appointed former Samsung Asset Management CEO Phillip (Bongkyun) Suh as Korea country manager and Seoul branch manager, succeeding Hyon Joo Park, who will retire in March. At the same time, BNY’s Pershing unit is preparing an Advisor Match service that links retail investors with RIAs on its platform, highlighting the firm’s push to deepen distribution and advice-focused offerings. We’ll now examine how Suh’s appointment in Korea could influence...

In recent months, multiple law firms have launched class action lawsuits and shareholder investigations accusing CarMax of overstating its growth prospects, while the company simultaneously announced leadership changes, price cuts, and margin reductions to revive used-vehicle sales. These legal challenges and management shifts raise fresh questions about how much of CarMax’s earlier momentum reflected sustainable demand versus temporary tariff-driven buying. Next, we’ll examine how these...

If you are wondering whether Cencora’s share price still offers value after a strong run, this article walks through what the numbers actually say about the stock. The share price sits at US$335.74, with returns of 42.3% over 1 year, 109.3% over 3 years and 235.9% over 5 years, even though the stock has seen small pullbacks of 0.6% over the last week and 0.5% over the last month, and a 0.9% decline year to date. Recent coverage has focused on Cencora’s role as a large healthcare distributor...

State Street Corporation recently announced it has been appointed as the service provider for Columbia Threadneedle Investments’ newly launched UCITS actively managed ETFs, initially covering US and European equities with Emerging Markets and Global products expected to follow. This mandate underlines State Street’s breadth in end-to-end ETF servicing across custody, fund accounting, basket creation, order management and reporting for global asset managers. Next, we’ll examine how this new...

Patterson-UTI Energy (PTEN) is back in focus after reporting an average of 93 to 94 drilling rigs operating in the U.S., along with a larger North American footprint following its merger with NexTier. See our latest analysis for Patterson-UTI Energy. The recent update on rig activity comes as the share price has gained 30.91% over the past 90 days and 11.23% over the past 30 days. However, the 1 year total shareholder return of a 12.05% decline and 3 year total shareholder return of a 54.98%...

In early January 2026, analysts at Barclays reaffirmed a positive rating on Kontoor Brands while revising their expectations amid persistent consumer demand uncertainty in the specialty retail sector. This mixed signal, cautious on the demand backdrop yet still constructive on the business, sparked a reassessment of how resilient Kontoor’s apparel brands may be under shifting spending patterns. Next, we’ll examine how Barclays’ emphasis on ongoing demand uncertainty could influence Kontoor...

Why Copa Holdings Stock Is Back in Focus Copa Holdings (NYSE:CPA) has drawn fresh attention after a recent share price surge tied to optimism about air travel demand, passenger revenue growth and fleet expansion, even as earnings estimates have softened. See our latest analysis for Copa Holdings. The recent spike that took Copa Holdings to a fresh 52 week high, alongside its 10.93% 1 month share price return and 54.69% 1 year total shareholder return, points to momentum building rather than...

In early January 2026, DocuSign drew mixed analyst reactions as sluggish annual recurring revenue growth contrasted with rapid expansion of its intelligent agreement management customer base and improving operating efficiency. This tension between weak long-term commitments from customers and accelerating adoption of DocuSign’s newer AI-enabled offerings raises important questions about the company’s next phase of growth. We’ll now examine how accelerating intelligent agreement management...

In recent days, investors rotated into defensive and industrial names after former President Trump called for a very large proposed US$1.50 trillion U.S. defense budget for 2027, lifting sentiment toward engineered components suppliers such as Gates Industrial. This shift highlights how expectations for higher government defense spending can improve investor interest in companies supplying critical engineered systems across multiple industrial end markets. We’ll now examine how heightened...

Molina Healthcare recently faced heightened scrutiny after elevated medical costs and revised 2025 profit guidance, especially in its Medicare and Marketplace segments, contributed to a sharp earnings disappointment and subsequent legal investigations into potential disclosure issues. These developments have left analysts divided on the company’s outlook, with ratings ranging from cautious to positive as they reassess how reliably Molina can align premiums with its underlying medical cost...

In recent sessions, Sociedad Química y Minera de Chile has highlighted its low-cost lithium operations and diversified fertilizer and industrial chemicals businesses as it faces a lithium downcycle and regulatory uncertainty in Chile. This combination of cost discipline, business diversification, and early signs of stabilization in trading activity is drawing renewed investor attention to the company’s lithium-focused long-term plans. We’ll now examine how SQM’s emphasis on cost leadership...

D-Wave Quantum Inc. recently reported an industry-first breakthrough in gate-model quantum computing, successfully achieving scalable on-chip cryogenic control of qubits that sharply cuts wiring complexity while preserving qubit fidelity. By adapting the cryogenic control technology already used to manage tens of thousands of qubits in its annealing systems, D-Wave is extending its dual-platform roadmap and aiming to make large-scale gate-model processors more practical to build and...